Loading...
Ang Taizhou City Government sa Zhejiang China ay nag anunsyo na ang Favilavir,isang anti-viral drug na nagpapakita ng pagiging epektibo sa paggamot sa coronavirus disease (COVID-19),ay inaprubahan para sa marketing.
Ayon sa China Daily Report nitong Lunes:
Favilavir, formerly known as Fapilavir, was the first anti-novel coronavirus drug approved for marketing by China's National Medical Products Administration.
Meanwhile, the Ministry of Science and Technology said on Saturday that Favilar, which was developed by the Zhejiang Hisun Pharmaceutical Company, was one of the three drugs which showed efficacy in treating the COVID-19 in clinical trials.
YOU MAY READ THIS:
- Wuhan Crematorium Working 24/7 at nasa 100 na katawan ang Sinusunog Araw-araw.
- First Briton na na Contract ng Coronavirus,Gumaling Umano Dahil sa Whiskey at Lemon?
- Isa pang MISTERYOSONG Bagong Virus Lumabas sa Lawa ng Brazil,Ayon sa mga Scientists.
Ang gamot na Favilavir ay uumpisahan ang production nitong linggo. Halos lumubo naman ang bilang ng mga nasawi sa covid-19 na nasa 1,700 mahigit nitong lunes.
Ayon naman sa ulat ng GMA News:
In the Philippines, the number of persons under investigation for possible COVID-19 infection is down to 171, the Department of Health said.
In a press briefing earlier, Health Assistant Secretary Dr. Maria Rosario Vergeire said 350 others have already been discharged, including the two confirmed cases who managed to recover and the other who died after testing positive for the epidemic.
Of the 521 suspected cases, three tested positive, 453 tested negative, 22 are still awaiting for results, while others have yet to submit their specimens.
Loading...